Upstream Bio UPB
NASDAQ UPB
$6.01 -0.07 (-1.15%)
As of: Sep 4, 2026 · 3:59 PM EDT

Upstream Bio (UPB) Other Non-Current Assets (2024 - 2026)

Upstream Bio (UPB) posted quarterly Other Non-Current Assets of $194000.0 for Q1 2026, little changed year-over-year from $194000.0 in Q1 2025, and little changed quarter-over-quarter from $194000.0 in Q4 2025.

Analysis

Upstream Bio (UPB) Other Non-Current Assets (2024 - 2026) Analysis & Trends

Upstream Bio's Other Non-Current Assets history runs 3 years deep, the most recent figure standing at $194000.0 for Q1 2026.

  • In Q1 2026, Other Non-Current Assets changed 0.0% year-over-year to $194000.0; the TTM figure through Mar 2026 stood at $194000.0 (changed 0.0% YoY), while the FY2025 annual figure was $194000.0, changed 0.0% from the prior year.
  • Other Non-Current Assets for Q1 2026 stood at $194000.0, roughly flat from $194000.0 in the prior quarter.
  • The five-year high for Other Non-Current Assets was $194000.0 in Q3 2024, with the low at $194000.0 in Q3 2024.
  • The 3-year median for Other Non-Current Assets is $194000.0 (2024), against an average of $194000.0.
  • Peak annual rise in Other Non-Current Assets reached 0.0% in 2025, while the deepest fall reached 0.0% in 2025.
  • Upstream Bio's Other Non-Current Assets stood at $194000.0 in 2024, then changed by 0.0% to $194000.0 in 2025, then changed by 0.0% to $194000.0 in 2026.
  • Business Quant data shows UPB's Other Non-Current Assets at $194000.0 in Q1 2026, $194000.0 in Q4 2025, and $194000.0 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.25 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 2.31 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 124.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 618.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 42.45 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 109.58 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 65.13 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 62.96 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 104.44 Mn
10 Upstream Bio 327.95 Mn 327.95 Mn -3.29 Mn 194,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 194,000.00
Mar 31, 2026 194,000.00
Dec 31, 2025 194,000.00
Sep 30, 2025 194,000.00
Jun 30, 2025 194,000.00
Mar 31, 2025 194,000.00
Dec 31, 2024 194,000.00
Sep 30, 2024 194,000.00